Doctor Profile Image

Paul M. Yonover MD FACS

Urologist

  • “Dr. Yonover has consistently given me wonderful care.. and advice. He's empathetic and very knowledgeable. I also appreciate how he will always approach my care as worrying with me rather than telling me what i need to do. He's built tremendous confidence in him. As a patient I couldn't ask for a better doctor. i trust and respect him tremendously.”

Paul M. Yonover MD FACS


Dr. Paul Yonover is a board-certified urologist with UroPartners, providing comprehensive urologic care to patients throughout the Chicago area. He specializes in the diagnosis and treatment of prostate, bladder, and kidney conditions, as well as benign prostate enlargement, kidney stone disease, erectile dysfunction.

Dr. Yonover earned his bachelor’s degree from Indiana University, where he completed a double major in Biology and History. He went on to receive his Doctor of Medicine from the Mount Sinai School of Medicine in New York City. He completed residency training in general surgery and urology at Loyola University Medical Center in Maywood, Illinois, gaining broad experience in both medical and surgical urology.

In addition to his clinical practice, Dr. Yonover has been actively involved in urologic research and has published in numerous peer reviewed medical journals. He is the Chief Data Officer. He also serves as a Clinical Assistant Professor of Urology at the University of Illinois at Chicago College of Medicine, reflecting his commitment to medical education and advancing the field of urology. He served as the president of the Chicago Urological Society and lectures around the world on the use of molecular imaging and prostate cancer.

Dr. Yonover holds leadership roles as Chief of Urology at Advocate Illinois Masonic Medical Center and Ascension Presence Saint Joseph Hospital. His approach to care emphasizes evidence-based treatment, clear communication, and individualized planning to help patients understand their condition and treatment options.

Conditions Treated

Dr. Yonover evaluates and treats a wide range of urologic conditions, including:

  • Prostate conditions
    • Benign prostatic hyperplasia (BPH)
    • Prostate cancer
    • Lower urinary tract symptoms
  • Kidney and urinary tract conditions
    • Kidney stones
    • Kidney cancer
    • Urinary obstruction
  • Bladder conditions
    • Bladder cancer
    • Blood in the urine (hematuria)
    • Urinary symptoms and dysfunction
  • Men’s Health
    • Low Testosterone
    • Erectile Dysfunction
    • Desired Sterility/Fertility
  • General urologic concerns
    • Voiding difficulties
    • Follow-up care for complex urologic conditions
Procedures & Treatments

Dr. Yonover offers comprehensive urologic care using both medical and surgical approaches, tailored to each patient’s needs. Services may include:

  • Medical management
    • Medications for BPH and urinary symptoms
    • Nonsurgical treatment options when appropriate
  • Kidney stone treatment
    • Evaluation and treatment of stone disease
    • Surgical intervention for symptomatic stones
  • Diagnostic and follow-up care
    • Cancer evaluation and ongoing monitoring
    • Coordination of care across hospital and outpatient settings
  • Vasectomy

 

Awards and Credentials
  • Castle Connolly Regional Top Doctors: 1st Edition
  • Chicago Magazine's Top Cancer Doctors in Chicago: 2017, 2019, 2022, 2026
  • Chicago Magazine's Top Doctors in Chicago: 2022, 2023, 2024, 2025
  • Centers for Medicare & Medicaid Services, Meaningful Use Stage 1 Certification: 2012
  • Physician Community Service Award, Resurrection Saint Joseph Hospital, 2007
  • Chicago Urological Society Huggins Essay Contest - Paper, First Place Award, 2003
  • Praecis Pharmaceuticals/AUA Gerald P. Murphy Scholar, 2002
  • National Institute of Health (NIH) Summer Research Fellowship, 1995
  • Alpha Lambda Delta Honor Society, 1990
  • Phi Eta Sigma Freshman Honor Society, 1990

Hospital Affiliation
Advocate Illinois Masonic Hospital - Chicago, IL
Ascension Saint Joseph Hospital - Chicago, IL

Education and Training

1999 - 2003
Loyola University Medical Center, Chicago, Illinois United States
Residency - Urology
1997 - 1999
Loyola University Medical Center, Chicago, Illinois United States
Residency - General Surgery
1997 - 1998
Loyola University Medical Center, Chicago, Illinois United States
Internship - Transitional Year
1993 - 1997
Mount Sinai School of Medicine, New York, New York United States
Doctor of Medicine
1989 - 1993
Indiana University, Bloomington, Indiana United States
Bachelor of Arts - Biology and History

Certification
Illinois State Medical License
American Board of Urology

Societies
Chicago Urological Society
Fellow of the American College of Surgeons
American Board of Urology

Special Interests
Kidney, Bladder, Prostate, and Testicular Cancer
Kidney Stones
BPH
Laser Surgery of the Urinary Tract
Laparoscopic Surgery
Da Vinci Robotic Surgery

Enzalutamide in Men with Nonmetastic, Castration-Resistant Prostate Cancer

The New England Journal of Medicine - June 28, 2018

Prostate Cancer Screening Podcast

Noted urologist makes virtual house calls for Iowans

CBS 2 Iowa

Chicago-based Urologist offers Virtual clinic to assist patients during Covid-19

News Channel 20

Chicago urologist to make virtual house calls in Northwest Indiana during COVID-19 outbreak

The Times of Northwestern Indiana

Hydrogel spacer use during prostate RT: Community experience

In this article, we discuss one particular new product and how it may herald a significant change in the landscape of radiation therapy for prostate cancer.

Metastatic Male Breast Cancer With Increased Uptake on 18F-Fluciclovine PET/CT Scan

Gill HS, Tade F, Greenwald DT, Yonover PM, Savir-Baruch B. Clin Nucl Med. 2018 Jan;43(1):23-24. doi: 10.1097/RLU.0000000000001893. PMID: 29189374

Fluorine-18-Labeled Fluciclovine PET/CT in Clinical Practice: Factors Affecting the Rate of Detection of Recurrent Prostate Cancer

Savir-Baruch B, Lovrec P, Solanki AA, Adams WH, Yonover PM, Gupta G, Schuster DM. AJR Am J Roentgenol. 2019 Oct;213(4):851-858. doi: 10.2214/AJR.19.21153. Epub 2019 Jun 19. PMID: 31216198

Role of Nephrectomy in Metastatic Kidney Cancer

Yonover PM, Sharma SK, Flanigan RC. Cancer Treat Res. 2003;116:119-35. doi: 10.1007/978-1-4615-0451-1_7. PMID: 14650829 Review. No abstract available.

The Role of Resection for Patients With Renal Carcinoma

Flanigan RC, Yonover PM. Curr Oncol Rep. 2001 Sep;3(5):424-32. doi: 10.1007/s11912-001-0029-0. PMID: 11489244 Review.

Should Radical Nephrectomy Be Performed in the Face of Surgically Incurable Disease?

Yonover PM, Flanigan RC. Curr Opin Urol. 2000 Sep;10(5):429-34. doi: 10.1097/00042307-200009000-00011. PMID: 11005447 Review.

The Role of Radical Nephrectomy in Metastatic Renal Cell Carcinoma

Flanigan RC, Yonover PM. Semin Urol Oncol. 2001 May;19(2):98-102. PMID: 11354539 Review.

Correlation of Radiation Dose and Impotence Risk After Three-Dimensional Conformal Radiotherapy for Prostate Cancer

Mulhall JP, Yonover PM. Urology. 2001 Nov;58(5):828. doi: 10.1016/s0090-4295(01)01415-7. PMID: 11711377 No abstract available.

Mastication Steal: An Unusual Precipitant of Cerebrovascular Insufficiency

Fox D, Herron BE, Yonover PM, Baker WH. J Vasc Surg. 1999 Apr;29(4):734-6. doi: 10.1016/s0741-5214(99)70325-3. PMID: 10194507 Free article.